{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:31:20Z","timestamp":1792189880807,"version":"4.4.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"13","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,9]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Decision analysis can play an essential role in informing practice guidelines. The American Society of Hematology (ASH) thrombophilia guidelines have made a significant step forward in demonstrating how decision modeling integrated within Grading of Recommendations Assessment, Developing, and Evaluation (GRADE) methodology can advance the field of guideline development. Although the ASH model was transparent and understandable, it does, however, suffer from certain limitations that may have generated potentially wrong recommendations. That is, the panel considered 2 models separately: after 3 to 6\u00a0months of index venous thromboembolism (VTE), the panel compared thrombophilia testing (A) vs discontinuing anticoagulants (B) and testing (A) vs recommending indefinite anticoagulation to all patients (C), instead of considering all relevant options simultaneously (A vs B vs C). Our study aimed to avoid what we refer to as the omitted choice bias by integrating 2 ASH models into a single unifying threshold decision model. We analyzed 6 ASH panel's recommendations related to the testing for thrombophilia in settings of \u201cprovoked\u201d vs \u201cunprovoked\u201d VTE and low vs high bleeding risk (total 12 recommendations). Our model disagreed with the ASH guideline panels\u2019 recommendations in 4 of the 12 recommendations we considered. Considering all 3 options simultaneously, our model provided results that would have produced sounder recommendations for patient care. By revisiting the ASH guidelines methodology, we have not only improved the recommendations for thrombophilia but also provided a method that can be easily applied to other clinical problems and promises to improve the current guidelines\u2019 methodology.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024012931","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:43:51Z","timestamp":1713289431000},"page":"3596-3606","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines"],"prefix":"10.1182","volume":"8","author":[{"given":"Benjamin","family":"Djulbegovic","sequence":"first","affiliation":[{"name":"1Division of Medical Hematology and Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2349-5707","authenticated-orcid":false,"given":"Iztok","family":"Hozo","sequence":"additional","affiliation":[{"name":"2Department of Mathematics, Indiana University Northwest, Gary, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"3","key":"2024071211110664000_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/jep.13953","article-title":"Improving methods of clinical practice guidelines: from guidelines to pathways to fast-and-frugal trees and decision analysis to develop individualized patient care","volume":"30","author":"Djulbegovic","year":"2024","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"5","key":"2024071211110664000_bib2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/jep.12857","article-title":"Going from evidence to recommendations: can GRADE get us there?","volume":"24","author":"Mercuri","year":"2018","journal-title":"J\u00a0Eval Clin Pract"},{"key":"2024071211110664000_bib3","author":"Djulbegovic","year":"2023"},{"issue":"3","key":"2024071211110664000_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jep.13809","article-title":"Decomposing clinical practice guidelines panels' deliberation into decision theoretical constructs","volume":"29","author":"Djulbegovic","year":"2023","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"1","key":"2024071211110664000_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jep.13780","article-title":"Evaluation of a fast-and-frugal clinical decision algorithm (\u2018pathways\u2019) on clinical outcomes in hospitalized patients with COVID-19 treated with anticoagulants","volume":"29","author":"Djulbegovic","year":"2023","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"6","key":"2024071211110664000_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jep.13851","article-title":"Sorites paradox and persistence in overuse and underuse in healthcare delivery services","volume":"29","author":"Djulbegovic","year":"2023","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"1","key":"2024071211110664000_bib7","first-page":"E6","article-title":"Linking evidence-based medicine therapeutic summary measures to clinical decision analysis","volume":"2","author":"Djulbegovic","year":"2000","journal-title":"MedGenMed"},{"issue":"10092","key":"2024071211110664000_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(16)31592-6","article-title":"Progress in evidence-based medicine: a quarter century on","volume":"390","author":"Djulbegovic","year":"2017","journal-title":"Lancet"},{"key":"2024071211110664000_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2021.02.025","article-title":"Certainty of evidence and intervention's benefits and harms are key determinants of guidelines\u2019 recommendations","volume":"136","author":"Djulbegovic","year":"2021","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"22","key":"2024071211110664000_bib10","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"7650","key":"2024071211110664000_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2024071211110664000_bib12","first-page":"89","author":"Wooldridge","year":"2009"},{"issue":"19","key":"2024071211110664000_bib13","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"2024071211110664000_bib14","author":"Sox","year":"2013","edition":"2nd Ed."},{"issue":"3","key":"2024071211110664000_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0167-6296(98)00039-3","article-title":"The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies","volume":"18","author":"Claxton","year":"1999","journal-title":"J\u00a0Health Econ"},{"issue":"2","key":"2024071211110664000_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jep.13091","article-title":"The threshold model revisited","volume":"25","author":"Djulbegovic","year":"2019","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"20","key":"2024071211110664000_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM198005153022003","article-title":"The threshold approach to clinical decision making","volume":"302","author":"Pauker","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024071211110664000_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM197507312930505","article-title":"Therapeutic decision making: a cost benefit analysis","volume":"293","author":"Pauker","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"2024071211110664000_bib19","doi-asserted-by":"crossref","first-page":"e066045","DOI":"10.1136\/bmj-2021-066045","article-title":"Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis","volume":"375","author":"Yao","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"2024071211110664000_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/hematology.2023000492","article-title":"Provoked vs minimally provoked vs unprovoked VTE: does it matter?","volume":"2023","author":"Becattini","year":"2023","journal-title":"Hematology"},{"key":"2024071211110664000_bib21","volume-title":"Venous thromboembolic diseases: diagnosis, management and thrombophilia testing","year":"2023"},{"issue":"9383","key":"2024071211110664000_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"2024071211110664000_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejh.12884","article-title":"Retrospective evaluation of venous thromboembolism: are all transient provoking events the same?","volume":"99","author":"Chua","year":"2017","journal-title":"Eur J Haematol"},{"issue":"3","key":"2024071211110664000_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jep.13657","article-title":"High quality (certainty) evidence changes less often than low-quality evidence, but the magnitude of effect size does not systematically differ between studies with low versus high-quality evidence","volume":"28","author":"Djulbegovic","year":"2022","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"8","key":"2024071211110664000_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/jep.13915","article-title":"Generalized decision curve analysis for explicit comparison of treatment effects","volume":"29","author":"Hozo","year":"2023","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"2","key":"2024071211110664000_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jep.13945","article-title":"Decision curve analysis based on summary data","volume":"30","author":"Hozo","year":"2024","journal-title":"J\u00a0Eval Clin Pract"},{"issue":"2","key":"2024071211110664000_bib27","doi-asserted-by":"crossref","first-page":"e230010","DOI":"10.1001\/jamanetworkopen.2023.0010","article-title":"Validation of the ONKOTEV risk prediction model for venous thromboembolism in outpatients with cancer","volume":"6","author":"Cella","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2024071211110664000_bib28","first-page":"25","article-title":"How to think rationally about world problems","volume":"6","author":"Stanovich","year":"2018","journal-title":"J\u00a0Intell"},{"key":"2024071211110664000_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-37993-2_1","article-title":"Evidence and decision-making","volume":"189","author":"Djulbegovic","year":"2023","journal-title":"Cancer Treat Res"},{"issue":"1","key":"2024071211110664000_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1472-6947-12-94","article-title":"Dual processing model of medical decision-making","volume":"12","author":"Djulbegovic","year":"2012","journal-title":"BMC Med Inform Decis Mak"},{"key":"2024071211110664000_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-0-585-34290-0_11","volume-title":"Expertise and Decision Support","author":"Clark","year":"1992"},{"key":"2024071211110664000_bib32","author":"Stanovich","year":"2011"},{"issue":"6","key":"2024071211110664000_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.surg.2023.01.016","article-title":"Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer","volume":"173","author":"Cucchetti","year":"2023","journal-title":"Surgery"},{"key":"2024071211110664000_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-031-37993-2_3","article-title":"Making decisions when no further diagnostic testing is available (expected regret theory threshold model)","volume":"189","author":"Djulbegovic","year":"2023","journal-title":"Cancer Treat Res"},{"issue":"4","key":"2024071211110664000_bib35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0272989X08315249","article-title":"When is diagnostic testing inappropriate or irrational? acceptable regret approach","volume":"28","author":"Hozo","year":"2008","journal-title":"Med Decis Making"},{"key":"2024071211110664000_bib36","first-page":"323","article-title":"Clarification and corrections of acceptable regret model","volume":"29","author":"Hozo","year":"2009","journal-title":"Med Decis Making"},{"issue":"2","key":"2024071211110664000_bib37","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.pmed.0040026","article-title":"When should potentially false research findings be considered acceptable?","volume":"4","author":"Djulbegovic","year":"2007","journal-title":"PLoS Med"},{"key":"2024071211110664000_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-031-37993-2_8","article-title":"Which threshold model?","volume":"189","author":"Djulbegovic","year":"2023","journal-title":"Cancer Treat Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/13\/3596\/2234858\/blooda_adv-2024-012931-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/13\/3596\/2234858\/blooda_adv-2024-012931-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T11:11:29Z","timestamp":1720782689000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/13\/3596\/515755\/Decision-theoretical-foundations-of-clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012931","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]}}}